Rafael Holdings Inc. Class B Common Stock (RFL)

About RFL

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candi…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

21

Website

rafaelholdings.com

Fundamentals

1-day range

$2.41$2.82

Market cap

$105.04M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.68

Dividend yield

—

Beta

0.25

Avg. volume

210.8K

Rafael Holdings Inc. Class B Common Stock Competitors

Chosen by industry and closest market cap.

• RFL

  Rafael Holdings Inc. Class B Common Stock

  $2.52

  ▲ 6.33%
  Market cap $105.04MP/E —
  $1.12$3.96
• COYA

  Coya Therapeutics Inc. Common Stock

  $4.59

  ▼ 5.56%
  Market cap $107.43MP/E —
  $3.71$7.75
• PLYX

  Polaryx Therapeutics Inc. Common Stock

  $2.07

  ▼ 2.13%
  Market cap $110.66MP/E —
  $1.86$48.91
• NRXP

  NRX Pharmaceuticals Inc. Common Stock

  $3.54

  ▼ 2.21%
  Market cap $111.95MP/E —
• RANI

  Rani Therapeutics Holdings Inc. Class A Common Stock

  $0.845

  ▼ 1.05%
  Market cap $96.76MP/E —
  $0.44$3.87
• ALDX

  Aldeyra Therapeutics Inc. Common Stock

  $1.49

  ▼ 3.57%
  Market cap $95.91MP/E —
  $1.07$6.18
• ONCY

  Oncolytics Biotech Inc. Common Stock

  $0.8457

  ▼ 0.51%
  Market cap $95.55MP/E —
  $1.39$1.44

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held

2.39M

Total value held

$2.96M

Institutional holders

41